SCHEMBL620370

SCHEMBL620370

CC(C)C[C@H](N)C(=O)NCC(=O)O

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC7A5 Q01650 1/20 0.54
ALDH1A1 P00352 1/20 0.53
LMNA P02545 1/20 0.53
MAPT P10636 1/20 0.53
PTGS2 P35354 1/20 0.53
TDP1 Q9NUW8 1/20 0.53
ECE1 P42892 1/20 0.47
MME P08473 1/20 0.46
ACE P12821 1/20 0.46
CPA1 P15085 1/20 0.46
ACE2 Q9BYF1 1/20 0.46
LARS1 Q9P2J5 2/20 0.45
ANPEP P15144 3/20 0.44
RNPEP Q9H4A4 3/20 0.44
DNPEP Q9ULA0 2/20 0.44
SLC1A3 P43003 1/20 0.42
SLC1A2 P43004 1/20 0.42
CYP2D6 P10635 1/20 0.40
CYP2C19 P33261 1/20 0.40
PTGS1 P23219 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL620369 1.00 SLC7A5 (0.54) SLC7A5ALDH1A1LMNAMAPTPTGS2
SCHEMBL6047667 1.00 SLC7A5 (0.54) SLC7A5ALDH1A1LMNAMAPTPTGS2
Hydrochloric Acid SCHEMBL25317171 0.98 SLC7A5 (0.52) SLC7A5ALDH1A1LMNAMAPTPTGS2
Water SCHEMBL25363513 0.98 SLC7A5 (0.52) SLC7A5ALDH1A1LMNAMAPTPTGS2
Hydrochloric Acid SCHEMBL25317177 0.98 SLC7A5 (0.52) SLC7A5ALDH1A1LMNAMAPTPTGS2
Water SCHEMBL25363515 0.98 SLC7A5 (0.52) SLC7A5ALDH1A1LMNAMAPTPTGS2
SCHEMBL1036014 0.93 ALDH1A1 (0.47) SLC7A5ALDH1A1LMNAMAPTPTGS2
SCHEMBL11291916 0.93 ALDH1A1 (0.47) SLC7A5ALDH1A1LMNAMAPTPTGS2
SCHEMBL11291910 0.93 ALDH1A1 (0.47) SLC7A5ALDH1A1LMNAMAPTPTGS2
SCHEMBL2322417 0.93 ALDH1A1 (0.47) SLC7A5ALDH1A1LMNAMAPTPTGS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 735 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260077056-A1 LINKER-PAYLOAD COMPOUND, CONJUGATES AND APPLICATIONS THEREOF GENEQUANTUM HEALTHCARE SUZHOU CO LTD (CN) 2026-03-19 US claimed
EP-4653017-A1 ANTIBODY-DRUG CONJUGATE AND USE THEREOF Tyligand Bioscience (Shanghai) Limited (CN) 2025-11-26 EP claimed
EP-4601702-A1 LINKER-PAYLOAD COMPOUND, CONJUGATES AND APPLICATIONS THEREOF Genequantum Healthcare (Suzhou) Co., Ltd. (CN) 2025-08-20 EP claimed
EP-4578464-A1 PHARMACEUTICAL COMPOSITION OF ANTIBODY DRUG CONJUGATE Genequantum Healthcare (Suzhou) Co., Ltd. (CN) 2025-07-02 EP claimed
WO-2022218331-A9 LINKERS, CONJUGATES AND APPLICATIONS THEREOF GENEQUANTUM HEALTHCARE (SUZHOU) CO., LTD. (CN) 2025-06-19 WO claimed
WO-2025126157-A1 ANTI-IL-1RAP BINDING DOMAINS AND ANTIBODY-DRUG CONJUGATES THEREOF ADVESYA (FR) 2025-06-19 WO claimed
CN-119730886-A Pharmaceutical composition of antibody-conjugated drug 启德医药科技(苏州)有限公司 2025-03-28 CN claimed
CN-119497717-A Linker, conjugate and uses thereof 启德医药科技(苏州)有限公司 2025-02-21 CN claimed
WO-2025027529-A1 ANTI-IL-1RAP ANTIBODY DRUG CONJUGATES AND METHODS OF USE THEREOF ADVESYA (FR) 2025-02-06 WO claimed
CN-119185093-A Application of hydrolyzed aloe flower protein in skin repair product 完美(广东)日用品有限公司 2024-12-27 CN claimed
CN-1073113-C Camptothecin derivative and preparation method and application thereof TANABE SEIYAKU CO (JP) 2001-10-17 CN claimed
WO-2001060961-A1 STABLE, AQUEOUS COMPOSITIONS FOR TREATING SURFACES, ESPECIALLY FABRICS THE PROCTER & GAMBLE COMPANY (US) 2001-08-23 WO claimed
CN-1300733-A Comptothecin compounds and preparation thereof TANABE SEIYAKU CO (JP) 2001-06-27 CN claimed
CN-1036832-C Composition containing a penem or carbapenem artibiotic and the use of the same SANKYO CO (JP) 1997-12-31 CN claimed
CN-1158334-A Camptothecin derivatives TANABE SEIYAKU CO (JP) 1997-09-03 CN claimed
EP-0226304-B1 COMPOSITION CONTAINING A PENEM OR CARBAPENEM ANTIBIOTIC SANKYO COMPANY LIMITED (JP) 1991-08-28 EP claimed
US-4874695-A COLORIMETRIC ANALYSIS AMERICAN HOME PRODUCTS CORP. (US) 1989-10-17 US claimed
US-4757066-A Reduces renal toxicity SANKYO COMPANY LIMITED (JP) 1988-07-12 US claimed
EP-0226304-A1 Composition containing a penem or carbapenem antibiotic SANKYO COMPANY LIMITED (JP) 1987-06-24 EP claimed
CN-86107574-A Compositions containing penem or carbapenem antibiotics and their use 1987-05-20 CN claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260077056-A1 LINKER-PAYLOAD COMPOUND, CONJUGATES AND APPLICATIONS THEREOF CLTB, LNPEP, DCLRE1A SLC7A5 71/4885ALDH1A1 1827/4885LMNA 1064/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.